Industries > Pharma > NGS-Based RNA Sequencing Market Report 2021-2031

NGS-Based RNA Sequencing Market Report 2021-2031

Forecasts by Component (Sequencing Platforms, Sequencing Products, Kits and Reagents, Services), by Technology (Ion Semiconductor Sequencing, Pyrosequencing, Synthesis Sequencing (SBS), Real Time Sequencing (SMRT), Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing), by End-user (Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories) AND Regional and Leading National Market Analysis PLUS Analysis of Leading RNA Sequencing Companies AND COVID-19 Recovery Scenarios

PUBLISHED: 05 May 2021
PAGES: 330
PRODUCT CODE: PHA1131
SUBMARKET: Biotechnology

Clear
WOOCS 2.2.1
SKU: PHA1131 Categories: , Tags: ,

NGS Based RNA Sequencing Market to Witness Lucrative Growth Opportunities Owing to the Growing Demand for Advanced Gene Expression Analysis Over the Decade

Genome sequencing is being used to examine the spread of Covid-19, and it can help scientists further understand the implications of therapies and potential treatments. Big pharma and biotech players are also fully equipped to use the sequencing combat the pandemic. For example, Illumina the global leader in this market has supported the monitoring and transmission of virus through its technology implementation. Major market players are partnering with other businesses to expand the use of their platforms for testing and diagnostics. Some of the top companies are working towards creating NGS-powered solutions to diagnose cancers. The combination of next-generation sequencing (NGS) and bioinformatics tools has the ability to transform oncology discovery, diagnosis, and treatment. Advances in NGS technology will potentially result in progress in cancer research.

North America Currently Dominates the NGS Based RNA Sequencing Market
Based on regions, the NGS Based RNA-Sequencing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to Visiongain analysis, North America NGS Based RNA-Sequencing accounted for majority of the market share and is projected to witness significant growth over the forecast period from 2021 to 2031. The key factors driving the growth of the market in this region include presence of top life science players, technological in this region, advancement in the field of genomics, and increase in cancer prevalence. This is where your focus should be! To capture large in this market.

How do prominent players strengthen their position throughout the world?
Our newly updated report will help you explore the technologies and companies which hold greatest potential in this market. The report from Visiongain shows you potential revenues up to 2031, evaluate information, trends, opportunities and business outlooks. Gain a deep understanding of the competitive landscape with companies examined in this report in addition to their product portfolio, SWOT, latest research activities, the prioritized areas of investments, key strategies and initiatives. See where your expected gains will be.

Discover how to stay ahead
Our 330+ page report provides 241 tables and 227 charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing NGS Based RNA Sequencing Market. See how to exploit the opportunities.

Unique Covid-19 Impact Recovery Scenarios– This Visiongain report analyses 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy. By gaining access to these unique COVID-19 variations, you will be ready.

To access the data contained in this document please email contactus@visiongain.com

Which Factors are Driving NGS Based RNA Sequencing Market Growth?
• Increasing prevalence of cancer
• Government funding initiatives or life science projects
• Technological advancements in genomic-based bioinformatics tool

Which Factors are Restraining Growth?
• High cost associated with sequencing platforms establishment
• Low quality of outsourcing services
• Legal and ethical restrictions

What are the Market Opportunities?
• Immense opportunities to flourish in developing countries.
• Current advancements in the RNA sequencing workflow
• Growing focus in the genomic research and analysis

Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

NGS Based RNA Sequencing Market Segmentation

Component
• Sequencing Platforms
• Sequencing Products
• Kits & Reagent
• Services

Technology
• Ion Semiconductor Sequencing
• Pyro Sequencing
• Synthesis Sequencing
• Real Time Sequencing
• Ligation Sequencing
• Reversible Dye Termination Sequencing
• Nano-Pore Sequencing

End User
• Hospital laboratories
• Clinical Research Organizations
• Diagnostics
• Others

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

By Region

• North America
– U.S.
– Canada

• Europe
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe

• Asia Pacific
– China
– Japan
– India
– Rest of Asia Pacific

• South America
– Brazil
– Mexico
– Rest of South America

• MEA
– GCC
– Rest of MEA

NGS-Based RNA Sequencing Market Report 2021-2031
Need industry data? Please contact us today.

Leading countries and the potential for market growth
Overall world revenue for NGS Based RNA Sequencing will surpass $xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which regions hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 15 of the major companies involved in the NGS Based RNA Sequencing Market. Some of the companies profiled in this report include Illumina, Thermo Fisher Scientific, Takara Bio, Zymo Research, F. Hoffmann-La Roche, QIAGEN, PerkinElmer, Pacific Biosciences of California, Oxford Nanopore Technologies, Macrogen, Hamilton, Genewiz, BGI, Agilent Technologies, and Gatc Biotech.

Key Questions Answered by this Report:
• What is the NGS Based RNA Sequencing market status in 2020 and how it will evolve through 2031?
• What are the drivers, restraints, and opportunities of the NGS Based RNA Sequencing market?
• How will each NGS Based RNA Sequencing submarket segment grow over the forecast period and how much revenue will each segment account for in 2031?
• How will individual leading national markets perform over the forecast period, and what are their drivers and restraints?
• What have been the major developments of the leading national markets for NGS Based RNA Sequencing market over recent years, leading to their current market status?
• How will the market shares of the regional and leading national markets evolve by 2031, and which geographical region will lead in 2031?

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the NGS Based RNA Sequencing Market and leading companies. You will find data, trends, and predictions.

Who should read this report?
• Senior Executives
• Business Development Managers
• Marketing Directors
• Consultants
• Chief Executive Officers
• Governments, agencies & organizations actively working or interested in the NGS Based RNA Sequencing market will also find significant value in our research.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today NGS-Based RNA Sequencing Market Report 2021-2031: Forecasts by Component (Sequencing Platforms, Sequencing Products, Kits and Reagents, Services), by Technology (Ion Semiconductor Sequencing, Pyrosequencing, Synthesis Sequencing (SBS), Real Time Sequencing (SMRT), Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing), by End-user (Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories) AND Regional and Leading National Market Analysis PLUS Analysis of Leading RNA Sequencing Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for NGS-Based RNA Sequencing Market Report 2021-2031


Download sample pages

Complete the form below to download your free sample pages for NGS-Based RNA Sequencing Market Report 2021-2031


Latest Pharma news

Visiongain Publishes Cellular Immunotherapy Market Report 2021-2031

Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand for cellular immunotherapies.

15 June 2021

READ

Visiongain Publishes Gene Therapy R&D Market Report 2021-2031

Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions.

14 June 2021

READ

Visiongain Publishes Next Generation Sequencing Market Report 2021-2031

Rising preference for personalised medicine in developed as well as developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase NGS market concentration over the forecast period.

04 June 2021

READ

Visiongain Publishes Anti-infective Vaccines Market Report 2021-2031

The rising frequency of bacterial and viral diseases coupled with increased focus on immunisation programmes are two main reasons that are expected to boost the global anti-infective vaccines market’s growth in the coming years.

04 June 2021

READ

Categories